Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: Prevalence and associations in a cross-sectional study

被引:102
作者
San, Luis
Ciudad, Antonio
Alvarez, Enrique
Bobes, Julio
Gilaberte, Inmaculada
机构
[1] Lilly Res Labs SA, Madrid 28108, Spain
[2] Hosp San Rafael, Barcelona, Spain
[3] UAB, Hosp St Pau, Dept Psychiat, REM TAP, Barcelona, Spain
[4] Univ Oviedo, Fac Med, Area Psiquiatria, Oviedo, Spain
关键词
schizophrenia; remission; recovery; cross-sectional studies;
D O I
10.1016/j.eurpsy.2007.06.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose. - Progress in therapeutic options for schizophrenia has revived long-term expectations of researchers, practitioners and patients. At present, definitions of therapeutic outcome include both maintained symptomatic remission and appropriate functioning in a conceptual framework that targets patient's recovery as the ultimate goal. We aimed to know the prevalence and clinical features of patients with schizophrenia achieving these outcomes. Methods. - A multi-centre, cross-sectional study was performed in more than 100 mental health facilities within Spain. Recently published consensus-based operational criteria for symptomatic remission and the Global Assessment of Functioning scale were used to evaluate outcomes. Other clinical aspects like depressive symptoms, social cognition, premorbid adjustment and patients' attitudes to medication were also evaluated. Results. - Data from 1010 patients were analysed. Of these, 452 (44.8%) were at clinical remission, but only 103 (10.2%) showed an adequate social and/or vocational functioning. Factors predicting both outcomes were better pre-morbid adjustment (odds ratio, OR = 1.56) and better social cognitive function (OR = 1.14). Other factors, like treatment adherence, current or past psychotherapy and patient's age were not associated to functionality but only to clinical remission. Current substance use and previous rehabilitation were associated to a lower likelihood of symptomatic remission. Conclusion. - Although symptomatic remission in patients with schizophrenia is a realistic and reachable goal, future efforts should be directed to a sustained appropriate functioning in these patients. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:490 / 498
页数:9
相关论文
共 36 条
[1]   A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia [J].
Alvarez, Enrique ;
Ciudad, Antonio ;
Olivares, Jose Manuel ;
Bousono, Manuel ;
Gomez, Juan Carlos .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (03) :238-249
[2]  
American Psychiatric Association, 2000, DIAGN STAT MAN MENT
[3]   Remission in schizophrenia: Proposed criteria and rationale for consensus [J].
Andreasen, NC ;
Carpenter, WT ;
Kane, JM ;
Lasser, RA ;
Marder, SR ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (03) :441-449
[4]   POSITIVE VS NEGATIVE SCHIZOPHRENIA - A CRITICAL-EVALUATION [J].
ANDREASEN, NC .
SCHIZOPHRENIA BULLETIN, 1985, 11 (03) :380-389
[5]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789
[6]  
ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784
[7]   DEPRESSION, DEMORALIZATION AND CONTROL OVER PSYCHOTIC ILLNESS - A COMPARISON OF DEPRESSED AND NONDEPRESSED PATIENTS WITH A CHRONIC PSYCHOSIS [J].
BIRCHWOOD, M ;
MASON, R ;
MACMILLAN, F ;
HEALY, J .
PSYCHOLOGICAL MEDICINE, 1993, 23 (02) :387-395
[8]   MEASUREMENT OF PREMORBID ADJUSTMENT IN CHRONIC-SCHIZOPHRENIA [J].
CANNONSPOOR, HE ;
POTKIN, SG ;
WYATT, RJ .
SCHIZOPHRENIA BULLETIN, 1982, 8 (03) :470-484
[9]  
Ciudad A, 2004, ACTAS ESP PSIQUIATRI, V32, P227
[10]  
Docherty JP, 2007, INT CLIN PSYCHOPHARM, V22, P51